Originally published in our sister publication, Pain Medicine News.
The European League Against Rheumatism (EULAR) has issued provisional treatment recommendations for patients with rheumatic and musculoskeletal disease (RMD) who have contracted or tested positive for SARS-CoV-2, the virus causing COVID-19.
The recommendations, presented at the recent virtual EULAR annual meeting and published simultaneously in the Annals of the Rheumatic Diseases (2020;0:1-8), endorse continuing medications and